|
|
Article: Anesta Corp. Reports 2000 First Quarter Results; Actiq Prescriptions Increase 53%.
- Article from:
- PR Newswire
- Article date:
- April 17, 2000
CopyrightCOPYRIGHT 2000 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SALT LAKE CITY, April 17 /PRNewswire/ --
Anesta Corp.(Nasdaq: NSTA) reported a net loss for the quarter ended March 31, 2000 of $2,818,133, or $0.21 a share, compared to $2,889,635, or $0.22 a share for the quarter ended March 31, 1999. The decrease in net loss resulted primarily from increased product sales and licensing revenues.
Revenue for the quarter was $1,329,581, compared to $205,236 for the same period a year ago. Product sales and royalties were $934,023, compared to $34,088 for the same period a year ago.
At March 31, 2000, Anesta had cash, cash equivalents, marketable securities and a certificate of deposit totaling $65,054,251.
...